NCT00004033View on ClinicalTrials.gov

Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 1998

Primary Completion Date

May 31, 2001

Conditions
Malignant Mesothelioma
Interventions
DRUG

liposomal NDDP

PROCEDURE

therapeutic thoracoscopy

Trial Locations (2)

10016

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York

77030-4009

University of Texas - MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

NYU Langone Health

OTHER

NCT00004033 - Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma | Biotech Hunter | Biotech Hunter